Initial treatment of hypertension.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed.

1. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.European journal of clinical nutrition · 2015
   Trial
2. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.Current medical research and opinion · 2013
   Trial
3. Epicardial fat thickness is associated with retinopathy in patients with newly diagnosed hypertension.Northern clinics of Istanbul · 2021
   Article
4. Association of connexin gene polymorphism with essential hypertension in Kazak and Han Chinese in Xinjiang, China.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2017
   Article
5. Use of combination antihypertensive therapy initiation in older Americans without prevalent cardiovascular disease.Journal of the American Geriatrics Society · 2014
   Observational
6. Aldosterone synthase inhibitors in hypertension: current status and future possibilities.JRSM cardiovascular disease · 2014
   Review
7. QT Interval prolongation and dispersion: Epidemiology and clinical correlates in subjects with newly diagnosed systemic hypertension in Nigeria.Journal of cardiovascular disease research · 2012
   Article
8. Molecular mechanism of vitamin D in the cardiovascular system.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2011
   Review
9. [Referral criteria for benign prostatic hyperplasia in primary care].Atencion primaria · 2010
   Article
10. Risk of endometrial cancer in relation to medical conditions and medication use.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2009
    Article
11. Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.Vascular health and risk management · 2008
    Review
12. Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adults.BMC public health · 2007
    Article
13. Doctors and the public concord in their acceptance of antihypertensive drug treatment.Journal of human hypertension · 2006
    Article
14. Spontaneous renal artery dissection: three cases and clinical algorithms.Journal of human hypertension · 2006
    Article
15. Epidemiology, risk factors, and lifestyle modifications for gout.Arthritis research & therapy · 2006
    Review
16. Influence of the DASH diet and other low-fat, high-carbohydrate diets on blood pressure.Current atherosclerosis reports · 2005
    Review
17. Initial treatment of hypertension and adherence to therapy in general practice in Italy.European journal of clinical pharmacology · 2005
    Article
18. Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument for.Journal of clinical hypertension (Greenwich, Conn.) · 2005
    Article
19. Atherosclerotic Carotid Artery Occlusion.Current treatment options in cardiovascular medicine · 2003
    Article
20. Atherosclerotic Carotid Artery Occlusion.Current treatment options in neurology · 2003
    Article

Corrections and comments

• Commented on by
  Treating hypertension - what are we to believe?2003
• Commented on by
  Initial treatment of hypertension.2003
• Commented on by
  Initial treatment of hypertension.2003

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as